<DOC>
	<DOCNO>NCT02923284</DOCNO>
	<brief_summary>The incidence renal cell carcinoma ( RCC kidney cancer ) men exceed pancreatic cancer leukemia . In woman , incidence RCC similar leukemia , ovarian , pancreatic cancer ; thus , RCC significant health issue . This study focus identify specific molecule [ biomarkers ] RCC use develop reliable low-cost screening method point service . If successful , method would provide diagnostic test distinguish benign kidney mass malignant one , eliminate need surgically remove kidney benign tumor .</brief_summary>
	<brief_title>NANOTECH RCC Biomarkers</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<criteria>Patients 18 year age old undergoing surgery . Patient sample divide 2 group base surgery : Patients image renal mass , encompass 300 patients/year ( 1200 total ) malignant ( 8085 % time ) benign ( 1520 % time ) , patient nonkidney cancer , encompass 6,000 patients/year ( 24,000 total ) , Age &lt; 18 year prisoner .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>